Comparison of the HAT study, the largest global hypoglycaemia study to date, with similar large real‐world studies-Reference-Cited by-同舟云学术

Comparison of the HAT study, the largest global hypoglycaemia study to date, with similar large real‐world studies

Published:2019-04 Issue:4 Volume:21 Page:844-853
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Pedersen‐Bjergaard Ulrik¹^ORCID,Alsifri Saud²,Aronson Ronnie³^ORCID,Berković Maja Cigrovski⁴,Galstyan Gagik⁵,Gydesen Helge⁶,Lekdorf Jesper Barner⁷,Ludvik Bernhard⁸,Moberg Erik⁹,Ramachandran Ambady¹⁰,Khunti Kamlesh¹¹^ORCID

Affiliation:

1. Department of Endocrinology and NephrologyNordsjællands Hospital Hillerød Hillerød Denmark

2. Al Hada Military Hospital Taif Saudi Arabia

3. Endocrinology and MetabolismLMC Diabetes and Endocrinology Toronto Ontario Canada

4. University Hospital “Sestre Milosrdnice” Zagreb Croatia

5. Endocrinology Research Centre Moscow Russian Federation

6. EpidemiologyNovo Nordisk A/S Søborg Denmark

7. Global Medical Affairs and InsulinNovo Nordisk A/S Søborg Denmark

8. Division of Endocrinology and MetabolismRudolfstiftung Hospital and Karl‐Landsteiner Institute Vienna Austria

9. Karolinska Institutet Stockholm Sweden

10. India Diabetes Research Foundation Chennai India

11. Diabetes Research CentreUniversity of Leicester Leicester UK

Funder

Novo Nordisk

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.13588

Reference40 articles.

1. Increasing awareness of hypoglycaemia in patients with Type 2 diabetes treated with oral agents

2. Effects of patient-reported non-severe hypoglycemia on healthcare resource use, work-time loss, and wellbeing in insulin-treated patients with diabetes in seven European countries

3. Self‐reported non‐severe hypoglycaemic events in Europe

4. PREDICTIVE? ? a global, prospective observational study to evaluate insulin detemir treatment in types 1 and 2 diabetes: baseline characteristics and predictors of hypoglycaemia from the European cohort

5. Dosing Irregularities and Self-Treated Hypoglycemia in Type 2 Diabetes: Results from the Canadian Cohort of an International Survey of Patients and Healthcare Professionals

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence rate and risk factors for hypoglycemia among individuals with type 1 diabetes or type 2 diabetes in China receiving insulin treatment;Diabetes Research and Clinical Practice;2023-12

2. Patient and physician perspectives and experiences of basal insulin titration in type 2 diabetes in the United States: Cross‐sectional surveys;Diabetes, Obesity and Metabolism;2023-09-25

3. Severe (level 3) hypoglycaemia occurrence in a real‐world cohort of adults with type 1 or 2 diabetes mellitus (iNPHORM, United States);Diabetes, Obesity and Metabolism;2023-09-13

4. A real‐life comparison of hypoglycaemia symptomatology between insulin‐treated type 2 diabetes participants with and without impaired awareness of hypoglycaemia;Diabetic Medicine;2023-09-04

5. Gender differences in reported frequency and consequences of hypoglycemia among adults living with type 1 diabetes: Results from the BETTER registry;Diabetes Research and Clinical Practice;2023-08